Selected Publications
- Ustekinumab is safe and effective in pediatric patients with Crohn's disease. Elana B. Mitchel, Michael T. Dolinger, Brad Constant, Zi Wang, Daniela Guisado, Michael Gao, Steven Fusillo, Robert N. Baldassano, Judith Kelsen, Marla Dubinsky, Jing Huang, Lindsey Albenberg. Journal of Pediatric Gastroenterology and Nutrition
- Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch. Maia Kayal, Elizabeth A. Spencer, Matthew Smyth, Laura Raffals, Taha Qazi, Parakkal Deepak, Poonam Beniwal-Patel, Shannon Chang, Peter Higgins, Raymond K. Cross, Chelsea Anderson, Millie Long, Hans H. Herfarth, Marla C. Dubinsky, Edward L. Barnes. Inflammatory Bowel Diseases
- Author Correction: Gut microbiota strain richness is species specific and affects engraftment (Nature, (2025), 637, 8045, (422-429), 10.1038/s41586-024-08242-x). Alice Chen-Liaw, Varun Aggarwala, Ilaria Mogno, Craig Haifer, Zhihua Li, Joseph Eggers, Drew Helmus, Amy Hart, Jan Wehkamp, Esi S.N. Lamousé-Smith, Robert L. Kerby, Federico E. Rey, Jean Frédéric Colombel, Michael A. Kamm, Bernat Olle, Jason M. Norman, Rajita Menon, Andrea R. Watson, Emily Crossette, Elisabeth M. Terveer, Josbert J. Keller, Thomas J. Borody, Ari Grinspan, Sudarshan Paramsothy, Nadeem O. Kaakoush, Marla C. Dubinsky, Jeremiah J. Faith. Nature